Tag Archives | cancer vaccines immunotherapy

Biotechs Lag In Snap-Back Rally: CAR-T

Big Earnings Week-AACR Data Disappoints Roller Coaster Market This will be a big week for the market with 25% of all S&P companies reporting earnings. There is a broad rally today in all major indices up over 1% with the DOW leading helped by AAPL up 2.4% on more bullish prospects for the Apple Watch. […]

Continue Reading 0

Mid Cap Emerging Biopharmaceutical Companies: Valuations Do Matter for M&A

Update-1… On Onyx $10.4B Buyout By Amgen (AMGN) Valuation Models for  Biopharma Stocks -M&A Update In October 2013 we compared emerging biotech stocks after the acquisition of Onyx Pharmaceuticals by Amgen (AMGN). Now that rumors are “out there” for the acquisition of Pharmacyclics (PCYC) by large healthcare companies such as Johnson and Johnson (JNJ) and […]

Continue Reading 0

MO Players Take Profits Again in Biotech-Risk Off: AGIO, BLUE, JUNO, PBYI, KITE, ZIOP

NASDAQ at 4667  up 0.27%     XBI at $194.4 down 2.88% Clinical Stage Immuno-oncology Stocks Hit Hard Again Momentum traders took money off the table for the second time in three days. Most large cap biopharmaceutical stocks were in the red but down less than 1 % except Alexion (ALXN) down 2%.The Rayno Mid-Cap […]

Continue Reading 0

Rayno Life Science Stocks: YTD Review Part 1-FBT Up 49%

Part 1 Biopharmaceutical Stocks-New Highs Were Hit on December 10 Five Straight Years of Gains in Biotech-the IBB is up 292% since Dec 18, 2009 Biotech stocks are following the long term seasonal bullish trend surging in Q4 and up about 49 % YTD. The easiest way to invest in the biotech market is with […]

Continue Reading 0

Energy Weakness Rolls Over To Biotech Stocks Update-1… 12/12

Crude Trade Roils Markets-But Biotech Is Still A Safe Haven Second Worst Week of the Year-Late Day Trading Hit By Selling As the market becomes more volatile we should look at how the energy trade is affecting other asset classes. Certainly materials and industrials are being hit over the past month. With respect to healthcare […]

Continue Reading 0